Abstract:
The aim of this work was to study the improvement effect and mechanism of Mongolian astragalus polysaccharides(mAPS) on non-alcoholic fatty liver disease(NAFLD) in rats(Rattus norregicus). 50 male SD rats were randomly divided into five groups: control group(Ctrl group), Mongolian astragalus polysaccharide control group(mAPS group), model group(HFD group), Mongolian astragalus polysaccharides treatment group(HFD + mAPS group), and Berberine positive drug group(HFD + BER group). NAFLD rat model was constructed. Serum lipid related indicators and transaminase indicators were detected in NAFLD rats. HE staining was used to observe the pathological manifestations of liver tissue in NAFLD rats. RT-qPCR and Western blot were used to detect the mRNA and protein levels of Nrf-2-ARE signaling pathway related genes in the liver and colon of NAFLD rats. The results showed that mAPS could significantly decrease the levels of serum triglyceride(TG), total cholesterol(TC), low density lipoprotein(LDL), alanine ami-notransferase(ALT) and aspartate aminotransferase(AST)(P<0.05 or P<0.01) in NAFLD rats. Compared with Ctrl group, fat vacuoles and inflammatory cell accumulation appeared in HFD group. mAPS can improve liver damage induced by high-fat diet in NAFLD rats. RT-qPCR detection of the nuclear factor-erythroid 2-related factor 2-antioxidant response element(Nrf-2-ARE), nuclear factor-erythroid 2-related factor 2(Nrf-2), heme oxygenase-1(HO-1), superoxide dismutase(SOD), and glutamate cysteine ligase catalytic subunits(GCLC), showed that the mRNA expression of these genes were significantly decreased in the HFD group, After treatment with mAPS, the mRNA expression of these genes increased significantly(P<0.05 or P<0.01). At the same time, the protein level of Nrf-2-ARE signal pathway in liver and colon of NAFLD rats was detected, and the result was consistent with that of mRNA level. Research results showed that mAPS could improve lipid metabolism abnormalities in NAFLD rats, protect the liver and improve liver histopathological manifestations. mAPS may also alleviate oxidative stress in the liver and colon of NAFLD rats through Nrf-2-ARE signaling.